Treatment of patients with hematologic neoplasm, fever, and neutropenia

Clinical Infectious Diseases

Volumn 40, Issue SUPPL. 4, 2005, Pages

  Sepkowitz, Kent A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CARBOPLATIN; CEFTAZIDIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD DISEASE; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; FEBRILE NEUTROPENIA; FEMALE; FEVER; FUNGEMIA; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CANDIDIASIS; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOLITIS, NECROTIZING; FEMALE; FEVER; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 15744383689     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427330     Document Type: Article

References (17)

1. Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
2. Viscoli C, Bruzzi P, Castagnola E, et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1994; 30A:430-7.
3. Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 2002; 15:377-82.
4. Maschmeyer G, Noskin GA, Ribaud P, et al. Changing patterns of infections and antimicrobial susceptibilities. Oncology 2000; 14(Suppl 6):9-16.
5. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36:1103-10.
6. Meyer KS, Urban C, Eagan JA, et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-8.
7. Collin BA, Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am 1998; 12:781-805.
8. Neuhauser MM, Weinstein RA, Rydman R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289:885-8.
9. Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135:715-9.
10. Lawson RD, Gentry LO, Bodey GP, et al. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies. Am J Med Sci 1984; 287:16-23.
11. Chatzinikolaou I, Abi-Said D, Bodey GP, et al. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Arch Intern Med 2000; 160:501-09.
12. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
13. Persson L, Vikerfors T, Sjöberg L, et al. Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia. Scand J Infect Dis 2000; 32:615-21.
14. Viscoli C, Paesmans M, Sanz M, et al. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clin Infect Dis 2001; 32:1532-7.
15. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002; 34:1524-9.
16. Glenn J, Cotton D, Wesley R, et al. Anorectal infections in patients with malignant diseases. Rev Infect Dis 1988; 10:42-52.
17. Khan R, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 2003; 54:104-8.